185 related articles for article (PubMed ID: 6129981)
1. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.
Takenaka T; Asano M; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981
[TBL] [Abstract][Full Text] [Related]
2. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
Uchida W; Shibasaki K; Asano M; Takenaka T
Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
Farmer JB; Kennedy I; Levy GP; Marshall RJ
Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Uchida W; Shibasaki K; Asano M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
[TBL] [Abstract][Full Text] [Related]
6. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats.
Honda K; Nakagawa C; Inagaki O; Shibasaki M; Takenaka T; Takeda M
Jpn J Pharmacol; 1986 Aug; 41(4):459-66. PubMed ID: 2877109
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic sympathomimetic activity and coronary blood flow.
Berdeaux A; Giudicelli JF
Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
[TBL] [Abstract][Full Text] [Related]
8. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.
Fujii M; Shirasawa Y; Kondo S; Sawanobori K; Nakamura M
Jpn Heart J; 1986 Mar; 27(2):233-50. PubMed ID: 2873263
[TBL] [Abstract][Full Text] [Related]
10. alpha- and beta-receptor blockade of isoproterenol- and norepinephrine-induced effects on regional blood flow and blood flow acceleration.
Immink WF; Beijer HJ; Charbon GA
Eur J Pharmacol; 1978 Aug; 50(3):159-73. PubMed ID: 28954
[TBL] [Abstract][Full Text] [Related]
11. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
12. Cardiac effects of YM-09538, a new alpha- and beta-adrenoceptor blocking agent, on SA nodal pacemaker activity and contractility in isolated atria and intact dogs.
Chiba S; Watanabe H; Furukawa Y; Iwatsuki K
Jpn Heart J; 1982 Jul; 23(4):631-6. PubMed ID: 6127420
[TBL] [Abstract][Full Text] [Related]
13. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
[TBL] [Abstract][Full Text] [Related]
14. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs.
Kuhn FE; Johnson MN; Gillis RA; Visner MS; Schaer GL
J Am Coll Cardiol; 1990 Nov; 16(6):1481-91. PubMed ID: 2229802
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
[TBL] [Abstract][Full Text] [Related]
16. [Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)].
Katano Y; Takeda K; Nakagawa Y; Hashimoto T; Nakazawa M; Tsukada T; Otorii T; Imai S
Nihon Yakurigaku Zasshi; 1978 Oct; 74(7):819-32. PubMed ID: 33880
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
18. Comparison of airway obstruction induced by propranolol and YM-09538 (a combined alpha- and beta-adrenoceptor blocking drug).
Tomioka K; Yamada T; Takenaka T
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):97-107. PubMed ID: 6124220
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.
Kenny D; Pagel PS; Warltier DC
Basic Res Cardiol; 1992; 87(5):465-77. PubMed ID: 1334401
[TBL] [Abstract][Full Text] [Related]
20. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
